Telomerase in cancer: Clinical applications

References

• Watson J D. Origin of concatemeric T4 DNA. Nat New Biol 1972; 239: 197–201
   PubMedGoogle Scholar
• Olovnikov A M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973; 41: 181–90
   PubMed Web of Science ®Google Scholar
• Greider C W. Telomeres. Curr Opin Cell Biol 1991; 3: 444–51
   PubMed Web of Science ®Google Scholar
• Shay J W, Wright W E, Werbin H. Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta 1991; 1072: 1–7
   PubMed Web of Science ®Google Scholar
• Levy M Z, Allsopp R C, Futcher A B, Greider C W, Harley C B. Telomere end-replication problem and cell aging. J Mol Biol 1992; 225: 951–60
   PubMed Web of Science ®Google Scholar
• Sager R. Tumor suppressor genes: the puzzle and the promise. Science 1989; 246: 1406–12
   PubMed Web of Science ®Google Scholar
• Sager R. Senescence as a mode of tumor suppression. Environ Health Perspect 1991; 93: 59–62
   PubMed Web of Science ®Google Scholar
• Kipling D. The Telomere. Oxford University Press, Oxford 1995
   Google Scholar
• Blackburn E H, Greider C W. Telomeres. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1995
   Google Scholar
• Greider C W. Telomere length regulation. Annu Rev Biochem 1996; 65: 337–65
   PubMed Web of Science ®Google Scholar
• Wellinger R J, Sen D. The DNA structures at the ends of eukaryotic chromosomes. Eur J Cancer 1997; 33: 735–49
   PubMed Web of Science ®Google Scholar
• Meyne J, Ratliff R L, Moyzis R K. Conservation of the human telomere sequence (TTAGGG)n among vertebrates. Proc Natl Acad Sci USA 1989; 86: 7049–53
   PubMed Web of Science ®Google Scholar
• McElligott R, Wellinger R J. The terminal DNA structure of mammalian chromosomes. EMBO J 1997; 16: 3705–14
   PubMedGoogle Scholar
• Wang Y, Patel D. Solution structure of the human telomeric repeat β(AG3)3] G-tetraplex. Structure 1993; 1: 263–82
   PubMed Web of Science ®Google Scholar
• Laporte L, Thomas G J, Jr. Structural basis of DNA recognition and mechanism of quadruplex formation by the beta subunit of the Oxytricha telomere binding protein. Biochemistry 1998; 37: 1327–35
   PubMed Web of Science ®Google Scholar
• McClintock B. The stability of broken ends of chromosomes in Zea mays. Genetics 1941; 26: 234–82
   PubMedGoogle Scholar
• Sandell L L, Zakian V A. Loss of a yeast telomere: arrest, recovery, and chromosome loss. Cell 1993; 75: 729–39
   PubMed Web of Science ®Google Scholar
• van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 1998; 92: 401–13
   PubMed Web of Science ®Google Scholar
• Kirk K E, Harmon B P, Reichardt I K, Sedat J W, Blackburn E H. Block in anaphase chromosome separation caused by a telomerase template mutation. Science 1997; 275: 1478–81
   PubMed Web of Science ®Google Scholar
• Kurenova E V, Mason J M. Telomere functions. A review. Biochemistry (Mosc) 1997; 62: 1242–53
   PubMed Web of Science ®Google Scholar
• Shore D A. Telomere position effects and transcriptional silencing in the yeast Saccharomyces cerevisiae. Telomeres, E H Blackburn, C W Greider. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 1995; 139–91
   Google Scholar
• Blackburn E H. The telomere and telomerase: nucleic acid-protein complexes acting in a telomere homeostasis system. A review. Biochemistry (Mosc) 1997; 62: 1196–201
   PubMed Web of Science ®Google Scholar
• Marcand S, Gilson E, Shore D. A protein-counting mechanism for telomere length regulation in yeast. Science 1997; 275: 986–90
   PubMed Web of Science ®Google Scholar
• Shore D. Telomere length regulation: getting the measure of chromosome ends. Biol Chem 1997; 378: 591–7
   PubMed Web of Science ®Google Scholar
• Greider C W, Blackburn E H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43: 405–13
   PubMed Web of Science ®Google Scholar
• van Steensel B, de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature 1997; 385: 740–3
   PubMed Web of Science ®Google Scholar
• Shen M, Haggblom C, Vogt M, Hunter T, Lu K P. Characterization and cell cycle regulation of the related human telomeric proteins pin2 and TRF1 suggest a role in mitosis. Proc Natl Acad Sci USA 1997; 94: 13618–23
   PubMed Web of Science ®Google Scholar
• Smith S, de Lange T. TRF1, a mammalian telomeric protein. Trends Genet 1997; 13: 21–6
   PubMed Web of Science ®Google Scholar
• Konig P, Fairall L, Rhodes D. Sequence-specific DNA recognition by the Myb-like domain of the human telomere binding protein TRF1: a model for the protein-DNA complex. Nucleic Acids Res 1998; 26: 1731–40
   PubMed Web of Science ®Google Scholar
• Ray A, Runge K W. The C terminus of the major yeast telomere binding protein Raplp enhances telomere formation. Mol Cell Biol 1998; 18: 1284–95
   PubMed Web of Science ®Google Scholar
• Greider C W, Blackburn E H. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987; 51: 887–98
   PubMed Web of Science ®Google Scholar
• Lingner J, Hughes T R, Shevchenko A, Mann M, Lundblad V, Cech T R. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 1997; 276: 561–7
   PubMed Web of Science ®Google Scholar
• Counter C M, Meyerson M, Eaton E N, Weinberg R A. The catalytic subunit of yeast telomerase. Proc Natl Acad Sci USA 1997; 94: 9202–7
   PubMedGoogle Scholar
• Nakamura T M, Morin G B, Chapman K B, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955–9
   PubMed Web of Science ®Google Scholar
• Greenberg R A, Allsopp R C, Chin L, Morin G B, DePinho R A. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 1998; 16: 1723–30
   PubMedGoogle Scholar
• Meyerson M, Counter C M, Eaton E N, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997; 90: 785–95
   PubMed Web of Science ®Google Scholar
• Harrington L, Zhou W, McPhail T, et al. Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 1997; 11: 3109–15
   PubMed Web of Science ®Google Scholar
• Kilian A, Bowtell D D, Abud H E, et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 1997; 6: 2011–9
   PubMed Web of Science ®Google Scholar
• Nakayama J, Tahara H, Tahara E, et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998; 18: 65–8
   PubMed Web of Science ®Google Scholar
• Collins K, Greider C W. Tetrahymena telomerase catalyzes nucleolytic cleavage and nonprocessive elongation. Genes Dev 1993; 7: 1364–76
   PubMed Web of Science ®Google Scholar
• Greene E C, Bednenko J, Shippen D E. Flexible positioning of the telomerase-associated nuclease leads to preferential elimination of nontelomeric DNA. Mol Cell Biol 1998; 18: 1544–52
   PubMed Web of Science ®Google Scholar
• Weinrich S L, Pruzan R, Ma L, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 1997; 17: 498–502
   PubMed Web of Science ®Google Scholar
• Beattie T L, Zhou W, Robinson M O, Harrington L. Reconstitution of human telomerase activity in vitro. Curr Biol 1998; 8: 177–80
   PubMed Web of Science ®Google Scholar
• Counter C M, Meyerson M, Eaton E N, et al. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 1998; 16: 1217–22
   PubMed Web of Science ®Google Scholar
• Bodnar A G, Ouellette M, Frolkis M, et al. Extension of lifespan by introduction of telomerase into normal human cells. Science 1998; 279: 349–52
   PubMed Web of Science ®Google Scholar
• Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998; 8: 279–82
   PubMed Web of Science ®Google Scholar
• Shippen-Lentz D, Blackburn E H. Functional evidence for an RNA template in telomerase. Science 1990; 247: 546–52
   PubMed Web of Science ®Google Scholar
• Blasco M A, Funk W, Villeponteau B, Greider C W. Functional characterization and developmental regulation of mouse telomerase RNA. Science 1995; 269: 1267–70
   PubMed Web of Science ®Google Scholar
• Hinkley C S, Blasco M A, Funk W D, et al. The mouse telomerase RNA 5′-end lies just upstream of the telomerase template sequence. Nucleic Acids Res 1998; 26: 532–6
   PubMed Web of Science ®Google Scholar
• Feng J, Funk W D, Wang S S, et al. The RNA component of human telomerase. Science 1995; 269: 1236–41
   PubMed Web of Science ®Google Scholar
• Dokudovskaya S S, Petrov A V, Dontsova O A, Bogdanov A A. Telomerase is an unusual RNA-containing enzyme. A review. Biochemistry (Mosc) 1997; 62: 1206–15
   PubMed Web of Science ®Google Scholar
• Morin G B. The implications of telomerase biochemistry for human disease. Eur J Cancer 1997; 33: 750–60
   PubMed Web of Science ®Google Scholar
• Collins K, Kobayashi R, Greider C W. Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell 1995; 81: 677–86
   PubMed Web of Science ®Google Scholar
• Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F. TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 1997; 88: 875–84
   PubMed Web of Science ®Google Scholar
• Harrington L, McPhail T, Mar V, et al. A mammalian telomerase-associated protein. Science 1997; 275: 973–7
   PubMed Web of Science ®Google Scholar
• Harley C B. Telomere loss: mitotic clock or genetic time bomb?. Mutat Res 1991; 256: 271–82
   PubMed Web of Science ®Google Scholar
• Prowse K R, Greider C W. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 1995; 92: 4818–22
   PubMed Web of Science ®Google Scholar
• Bryant J E, Hutchings K G, Moyzis R K, Griffith J K. Measurement of telomeric DNA content in human tissues. Btotecbniques 1997; 23: 476–8
   PubMed Web of Science ®Google Scholar
• Shay J W. Accelerated telomere shortening in bone-marrow recipients (comment). Lancet 1998; 351: 153–4
   PubMed Web of Science ®Google Scholar
• Wynn R F, Cross M A, Hatton C, et al. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet 1998; 351: 178–81
   PubMed Web of Science ®Google Scholar
• Akiyama M, Hoshi Y, Sakurai S, Yamada H, Yamada O, Mizoguchi H. Changes of telomere length in children after hematopoietic stem cell transplantation. Bone Marrow Transplant 1998; 21: 167–71
   PubMed Web of Science ®Google Scholar
• Soder A I, Hoare S F, Muir S, Going J J, Parkinson E K, Keith W N. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 1997; 14: 1013–21
   PubMed Web of Science ®Google Scholar
• Soder Al, Going J J, Kaye S B, Keith W N. Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization. Oncogene 1998; 16: 979–83
   PubMed Web of Science ®Google Scholar
• Yashima K, Ashfaq R, Nowak J, et al. Telomerase activity and expression of its RNA component in cervical lesions. Cancer 1998; 82: 1319–27
   PubMed Web of Science ®Google Scholar
• Blasco M A, Rizen M, Greider C W, Hanahan D. Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 1996; 12: 200–4
   PubMed Web of Science ®Google Scholar
• Avilion A A, Piatyszek M A, Gupta J, Shay J W, Bacchetti S, Greider C W. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996; 56: 645–50
   PubMed Web of Science ®Google Scholar
• Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res 1998; 58: 1558–61
   PubMed Web of Science ®Google Scholar
• Tahara H, Yasui W, Nakayama J, et al (1998) Detection of hTRT protein expressing cells in human tumor tissues by immunohistochemical analysis. Proceedings of the AACR 89th Annual Meeting, New Orleans, LA, March, 28-April 11998. American Association for Cancer Research, Philadelphia
   Google Scholar
• Morin G B. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59: 521–9
   PubMed Web of Science ®Google Scholar
• Counter C M, Avilion A A, LeFeuvre C E, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992; 11: 1921–9
   PubMed Web of Science ®Google Scholar
• Counter C M, Hirte H W, Bacchetti S, Harley C B. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994; 91: 2900–4
   PubMed Web of Science ®Google Scholar
• Nilsson P, Mehle C, Remes K, Roos G. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene 1994; 9: 3043–8
   PubMed Web of Science ®Google Scholar
• Kim N W, Piatyszek M A, Prowse K R, et al. Specific-association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011–5
   PubMed Web of Science ®Google Scholar
• Wright W E, Shay J W, Piatyszek M A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995; 23: 3794–5
   PubMed Web of Science ®Google Scholar
• Ohyashiki J H, Ohyashiki K, Sano T, Toyama K. Non-radioisotopic and semi-quantitative procedure for terminal repeat amplification protocol. Jpn J Cancer Res 1996; 87: 329–31
   PubMedGoogle Scholar
• Poremba C, Bocker W, Willenbring H, et al. Telomerase activity in human proliferative breast lesions. Int J Oncol 1998; 12: 641–8
   PubMed Web of Science ®Google Scholar
• Ohyashiki K, Ohyashiki J H, Nishimaki J, et al. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res 1997; 57: 2100–3
   PubMed Web of Science ®Google Scholar
• Kim N W, Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 1997; 25: 2595–7
   PubMed Web of Science ®Google Scholar
• Norton J C, Holt S E, Wright W E, Shay J W. Enhanced detection of human telomerase activity. DNA Cell Biol 1998; 17: 217–9
   PubMed Web of Science ®Google Scholar
• Counter C M, Gupta J, Harley C B, Leber B, Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995; 85: 2315–20
   PubMed Web of Science ®Google Scholar
• Shay J W, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787–91
   PubMed Web of Science ®Google Scholar
• Meeker A K, Coffey D S. Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells. A review. Biochemistry I Mosc) 1997; 62: 1323–31
   PubMed Web of Science ®Google Scholar
• Nakatani K, Yoshimi N, Mori H, et al. The significant role of telomerase activity in human brain tumors. Cancer 1997; 80: 471–6
   PubMed Web of Science ®Google Scholar
• DeMasters B K, Markham N, Lillehei K O, Shroyer K R. Differential telomerase expression in human primary intracranial tumors. Am J Clin Pathol 1997; 107: 548–54
   PubMed Web of Science ®Google Scholar
• Langford L A, Piatyszek M A, Xu R, Schold S C, Jr, Shay J W. Telomerase activity in human brain tumours. Lancet 1995; 346: 1267–8
   PubMed Web of Science ®Google Scholar
• Gupta J, Han L P, Wang P, Gallie B L, Bacchetti S. Development of retinoblastoma in the absence of telomerase activity. J Natl Cancer Inst 1996; 88: 1152–7
   PubMed Web of Science ®Google Scholar
• Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 1996; 93: 6476–81
   PubMed Web of Science ®Google Scholar
• Yasumoto S, Kunimura C, Kikuchi K, et al. Telomerase activity in normal human epithelial cells. Oncogene 1996; 13: 433–9
   PubMed Web of Science ®Google Scholar
• Ramirez R D, Wright W E, Shay J W, Taylor R S. Telomerase activity concentrates in the mitotically active segments of human hair follicles. ] Invest Dermatol 1997; 108: 113–7
   PubMed Web of Science ®Google Scholar
• Broccoli D, Young J W, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad SciUSA 1995; 92: 9082–6
   PubMed Web of Science ®Google Scholar
• Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711–5
   PubMed Web of Science ®Google Scholar
• Igarashi H, Sakaguchi N. Telomerase activity is induced by the stimulation to antigen receptor in human peripheral lymphocytes. Biochem Biophys Res Commun 1996; 219: 649–55
   PubMed Web of Science ®Google Scholar
• Buchkovich K J, Greider C W. Telomerase regulation during entry into the cell cycle in normal human T cells. Mol Biol Cell 1996; 7: 1443–54
   PubMed Web of Science ®Google Scholar
• Weng N P, Levine B L, June C H, Hodes R J. Regulated expression of telomerase activity in human T lymphocyte development and activation. Exp Med 1996; 183: 2471–9
   PubMed Web of Science ®Google Scholar
• Norrback K F, Dahlenborg K, Carlsson R, Roos G. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 1996; 88: 222–9
   PubMed Web of Science ®Google Scholar
• Yamada O, Motoji T, Mizoguchi H. Up-regulation of telomerase activity in human lymphocytes. Biochim Biophys Acta 1996; 1314: 260–6
   PubMed Web of Science ®Google Scholar
• Bodnar A G, Kim N W, Effros R B, Chiu C P. Mechanism of telomerase induction during T cell activation. Exp Cell Res 1996; 228: 58–64
   PubMed Web of Science ®Google Scholar
• Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore M A. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 1997; 90: 182–93
   PubMed Web of Science ®Google Scholar
• Chiu C P, Dragowska W, Kim N W, et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 1996; 14: 239–48
   PubMed Web of Science ®Google Scholar
• Yui J, Chiu C P, Lansdorp P M. Telomerase activity in candidate stem cells from fetal liver and adult bone marrow. Blood 1998; 91: 3255–62
   PubMed Web of Science ®Google Scholar
• Lee H W, Blasco M A, Gottlieb G J, Horner J W, 2nd, Greider C W, DePinho R A. Essential role of mouse telomerase in highly proliferative organs. Nature 1998; 392: 569–74
   PubMed Web of Science ®Google Scholar
• Yashima K, Piatyszek M A, Saboorian H M, et al. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 1997; 50: 110–7
   PubMed Web of Science ®Google Scholar
• Brien T P, Kallakury B V, Lowry C V, et al. Telomerase activity in benign endometrium and endometrial carcinoma. Cancer Res 1997; 57: 2760–4
   PubMed Web of Science ®Google Scholar
• Kyo S, Takakura M, Kohama T, Inoue M. Telomerase activity in human endometrium. Cancer Res 1997; 57: 610–4
   PubMed Web of Science ®Google Scholar
• Saito T, Schneider A, Mattel N, et al. Proliferation-associated regulation of telomerase activity in human endometrium and its potential implication in early cancer diagnosis. Biochem Biophys Res Commun 1997; 231: 610–4
   PubMed Web of Science ®Google Scholar
• Yokoyama Y, Takahashi Y, Shinohara A, Lian Z, Tamaya T. Telomerase activity in the female reproductive tract and neoplasms. Gynecol Oncol 1998; 68: 145–9
   PubMed Web of Science ®Google Scholar
• Ramakrishnan S, Eppenberger U, Mueller H, Shinkai Y, Narayanan R. Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res 1998; 58: 622–5
   PubMed Web of Science ®Google Scholar
• Umbricht C B, Saji M, Westra W H, Udelsman R, Zeiger M A, Sukumar S. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma. Cancer Res 1997; 57: 2144–7
   PubMed Web of Science ®Google Scholar
• Kojima H, Yokosuka O, Imazeki F, Saisho H, Omata M. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 1997; 112: 493–500
   PubMed Web of Science ®Google Scholar
• Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 55: 2734–6
   PubMed Web of Science ®Google Scholar
• Nakashio R, Kitamoto M, Tahara H, Nakanishi T, Ide T, Kajiyama G. Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma. Int J Cancer 1997; 74: 141–7
   PubMed Web of Science ®Google Scholar
• Suda T, Isokawa O, Aoyagi Y, et al. Quantitation of telomerase activity in hepatocellular carcinoma: a possible aid for a prediction of recurrent diseases in the remnant liver. Hepatology 1998; 27: 402–6
   PubMed Web of Science ®Google Scholar
• Kyo S, Takakura M, Tanaka M, Kanaya T, Inoue M. Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions. Int J Cancer 1998; 79: 66–70
   PubMed Web of Science ®Google Scholar
• Leber B, Bacchetti S. Telomeres and telomerase in normal and malignant haematologic cells. Leuk Lymphoma 1996; 24: 1–9
   PubMed Web of Science ®Google Scholar
• Engelhardt M, Ozkaynak M F, Drullinsky P, et al. Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy. Leukemia 1998; 12: 13–24
   PubMed Web of Science ®Google Scholar
• Sugino T, Yoshida K, Bolodeoku J, et al. Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates. Int J Cancer 1996; 69: 301–6
   PubMed Web of Science ®Google Scholar
• Aogi K, Kitahara K, Buley I, et al. Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine needle aspirates. Clin Cancer Res 1998; 4: 1965–700
   PubMed Web of Science ®Google Scholar
• Gorham H, Yoshida K, Sugino T, et al. Telomerase activity in human gynaecological malignancies. J Clin Pathol 1997; 50: 501–4
   PubMed Web of Science ®Google Scholar
• Kyo S, Takakura M, Ishikawa H, et al. Application of telomerase assay for the screening of cervical lesions. Cancer Res 1997; 57: 1863–7
   PubMed Web of Science ®Google Scholar
• Zheng P S, Iwasaka T, Yokoyama M, Nakao Y, Pater A, Sugimori H. Telomerase activation in in vitro and in vivo cervical carcinogenesis. Gynecol Oncol 1997; 66: 222–6
   PubMed Web of Science ®Google Scholar
• Califano J, Ahrendt S A, Meininger G, Westra W H, Koch W M, Sidransky D. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res 1996; 56: 5720–2
   PubMed Web of Science ®Google Scholar
• Arai T, Yasuda Y, Takaya T, et al. Application of telomerase activity for screening of primary lung cancer in broncho-alveolar lavage fluid. Oncol Rep 1998; 5: 405–8
   PubMed Web of Science ®Google Scholar
• Yang C T, Lee M H, Lan R S, Chen J K. Telomerase activity in pleural effusions: diagnostic significance. J Clin Oncol 1998; 16: 567–73
   PubMed Web of Science ®Google Scholar
• Yoshida K, Sugino T, Goodison S, et al. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br J Cancer 1997; 75: 548–53
   PubMed Web of Science ®Google Scholar
• Yoshida K, Sugino T, Tahara H, et al. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Cancer 1997; 79: 362–9
   PubMed Web of Science ®Google Scholar
• Kavaler E, Landman J, Chang Y, Droller M J, Liu B C. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity. Cancer 1998; 82: 708–14
   PubMed Web of Science ®Google Scholar
• Kinoshita H, Ogawa O, Kakehi Y, et al. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. Natl Cancer Inst 1997; 89: 724–30
   Google Scholar
• Linn J F, Lango M, Halachmi S, Schoenberg M P, Sidransky D. Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder cancer patients. Int J Cancer 1997; 74: 625–9
   PubMed Web of Science ®Google Scholar
• Iwasaka T, Zheng P S, Yokoyama M, Fukuda K, Nakao Y, Sugimori H. Telomerase activation in cervical neoplasia. Obstet Gynecol 1998; 91: 260–2
   PubMed Web of Science ®Google Scholar
• Pao C C, Tseng C J, Lin C Y, et al. Differential expression of telomerase activity in human cervical cancer and cervical intraepithelial neoplasia lesions. J Clin Oncol 1997; 15: 1932–7
   PubMed Web of Science ®Google Scholar
• Shroyer K, Thompson L, Enomoto T, Eskens J, Shroyer A, McGregor J. Telomerase expression in normal epithelium, reactive atypia, squamous dysplasia, and squamous cell carcinoma of the uterine cervix. Am J Clin Pathol 1998; 109: 153–62
   PubMed Web of Science ®Google Scholar
• Scates D K, Muir G H, Venitt S, Carmichael P L. Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer?. Br J Urol 1997; 80: 263–8
   PubMedGoogle Scholar
• Zhang W, Kapusta L R, Slingerland J M, Klotz L H. Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium. Cancer Res 1998; 58: 619–21
   PubMed Web of Science ®Google Scholar
• Sommerfeld H J, Meeker A K, Piatyszek M A, Bova G S, Shay J W, Coffey D S. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 1996; 56: 218–22
   PubMed Web of Science ®Google Scholar
• Lin Y, Uemura H, Fujinami K, Hosaka M, Harada M, Kubota Y. Telomerase activity in primary prostate cancer. J Urol 1997; 157: 1161–5
   PubMed Web of Science ®Google Scholar
• Chadeneau C, Hay K, Hirte H W, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55: 2533–6
   PubMed Web of Science ®Google Scholar
• Tahara H, Kuniyasu H, Yokozaki H, et al. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1995; 1: 1245–51
   PubMed Web of Science ®Google Scholar
• Mehle C, Piatyszek M A, Ljungberg B, Shay J W, Roos G. Telomerase activity in human renal cell carcinoma. Oncogene 1996; 13: 161–6
   PubMed Web of Science ®Google Scholar
• Fiedler W, Dahse R, Schlichter A, et al. Telomerase activity and telomere length in different areas of renal cell carcinoma. Int J Oncol 1996; 9: 1227–32
   PubMed Web of Science ®Google Scholar
• Tahara E, Semba S, Tahara H. Molecular biological observations in gastric cancer. Semin Oncol 1996; 23: 307–15
   PubMed Web of Science ®Google Scholar
• Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res 1995; 55: 3258–62
   PubMed Web of Science ®Google Scholar
• Zhang W, Piatyszek M A, Kobayashi T, et al. Telomerase activity in human acute myelogenous leukemia - inhibition of telomerase activity by differentiation-inducing agents. Clin Cancer Res 1996; 2: 799–803
   PubMed Web of Science ®Google Scholar
• Langford L A, Piatyszek M A, Xu R, Schold S C, Jr, Wright W E, Shay J W. Telomerase activity in ordinary meningiomas predicts poor outcome. Hum Pathol 1997; 28: 416–20
   PubMed Web of Science ®Google Scholar
• Hiyama E, Gollahon L, Kataoka T, et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996; 88: 116–22
   PubMed Web of Science ®Google Scholar
• Clark G M, Osborne C K, Levitt D, Wu F, Kim N W. Telomerase activity and survival of patients with node-positive breast cancer. J Natl Cancer Inst 1997; 89: 1874–81
   PubMed Web of Science ®Google Scholar
• Hoos A, Hepp H H, Kaul S, Ahlert T, Bastert G, Wallwiener D. Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int J Cancer 1998; 79: 8–12
   PubMed Web of Science ®Google Scholar
• Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek M A, Shay J W. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995; 1: 249–55
   PubMed Web of Science ®Google Scholar
• Sugino T, Yoshida K, Bolodeoku J, Tarin D, Goodison S. Telomerase activity and its inhibition in benign and malignant breast lesions. J Pathol 1997; 183: 57–61
   PubMed Web of Science ®Google Scholar
• Katoh M, Katoh M, Kameyama M, Kugoh H, Shimizu M, Oshimura M. A repressor function for telomerase activity in telomerase-negative immortal cells. Mol Carcinog 1998; 21: 17–25
   PubMed Web of Science ®Google Scholar
• Steenbergen R D, Walboomers J M, Meijer C J, et al. Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. Oncogene 1996; 13: 1249–57
   PubMed Web of Science ®Google Scholar
• Ohmura H, Tahara H, Suzuki M, et al. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3. Jpn J Cancer Res 1995; 86: 899–904
   PubMedGoogle Scholar
• Loughran O, Clark L J, Bond J, et al. Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene 1997; 14: 1955–64
   PubMed Web of Science ®Google Scholar
• Parkinson E K, Newbold R F, Keith W N. The genetic basis of human keratinocyte immortalisation in squamous cell carcinoma development: the role of telomerase reactivation. Eur J Cancer 1997; 33: 727–34
   PubMed Web of Science ®Google Scholar
• Hiyama K, Ishioka S, Shirotani Y, et al. Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene 1995; 10: 937–44
   PubMed Web of Science ®Google Scholar
• Bacchetti S. Telomere maintenance in tumour cells. Cancer Surv 1996; 28: 197–216
   PubMedGoogle Scholar
• Yu G L, Bradley J D, Attardi L D, Blackburn E H. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 1990; 344: 126–32
   PubMed Web of Science ®Google Scholar
• Singer M S, Gottschling D E. TLC1: template RNA component of Saccharomyces cerevisiae telomerase. Science 1994; 266: 404–9
   PubMed Web of Science ®Google Scholar
• McEachem M J, Blackburn E H. Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 1995; 376: 403–9
   PubMed Web of Science ®Google Scholar
• Blasco M A, Lee H W, Hande M P, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997; 91: 25–34
   PubMed Web of Science ®Google Scholar
• Hamilton S E, Pitts A E, Katipally R R, et al. Identification of determinants for inhibitor binding within the RNA active site of human telomerase using PNA scanning. Biochemistry 1997; 36: 11873–80
   PubMed Web of Science ®Google Scholar
• Mata J E, Joshi S S, Palen B, et al. A hexameric phosphoro-thioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo. Toxicol Appl Pharmacol 1997; 144: 189–97
   PubMed Web of Science ®Google Scholar
• Zhao J Q, Hoare S F, McFarlane R, et al. Cloning and characterization of human and mouse telomerase RNA gene promoter sequences. Oncogene 1998; 16: 1345–50
   PubMed Web of Science ®Google Scholar
• Mandal M, Kumar R. Bcl-2 modulates telomerase activity. J Biol Chem 1997; 272: 14183–7
   PubMed Web of Science ®Google Scholar
• Klingelhutz A J, Foster S A, McDougall J K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996; 380: 79–82
   PubMed Web of Science ®Google Scholar
• Stoppler H, Hartmann D P, Sherman L, Schlegel R. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length. J Biol Chem 1997; 272: 13332–7
   PubMed Web of Science ®Google Scholar
• Kallassy M, Martel N, Damour O, Yamasaki H, Nakazawa H. Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAFl gene expression. Mol Carcinog 1998; 21: 26–36
   PubMed Web of Science ®Google Scholar
• Li H, Zhao L L, Funder J W, Liu J P. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J Biol Chem 1997; 272: 16729–32
   PubMed Web of Science ®Google Scholar
• Yegorov Y E, Chernov D N, Akimov S S, et al. Blockade of telomerase function by nucleoside analogs. Biochemistry (Mosc) 1997; 62: 1296–305
   PubMed Web of Science ®Google Scholar
• Melana S, Holland J, Pogo B. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3′-azido-3′-deoxythymidine. Clin Cancer Res 1998; 4: 693–6
   PubMed Web of Science ®Google Scholar
• Yamakuchi M, Nakata M, Kawahara K, Kitajima I, Maruyama I. New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines. Cancer Lett 1997; 119: 213–9
   PubMed Web of Science ®Google Scholar
• Burger A M, Double J A, Newell D R. Inhibition of telomerase activity by cisplatin in human testicular cancer cells. Eur J Cancer 1997; 33: 638–44
   PubMed Web of Science ®Google Scholar
• Ishibashi T, Lippard S J. Telomere loss in cells treated with cisplatin. Proc Natl Acad Sci USA 1998; 95: 4219–23
   PubMed Web of Science ®Google Scholar
• Murnanc J P, Sabaticr L, Marder B A, Morgan W F. Telomere dynamics in an immortal human cell line. EMBO J 1994; 13: 4953–62
   PubMed Web of Science ®Google Scholar
• Bryan T M, Englezou A, Gupta J, Bacchetti S, Reddel R R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 1995; 14: 4240–8
   PubMed Web of Science ®Google Scholar
• Rogan E M, Bryan T M, Hukku B, et al. Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol 1995; 15: 4745–53
   PubMed Web of Science ®Google Scholar
• Reddel R R, Bryan T M, Murnane J P. Immortalized cells with no detectable telomerase activity. A review. Biochemistry (Mosc) 1997; 62: 1254–62
   PubMed Web of Science ®Google Scholar
• Bryan T M, Englezou A, Dalla-Pozza L, Dunham M A, Reddel R R. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 1997; 3: 1271–4
   PubMed Web of Science ®Google Scholar
• Wang S S, Zakian V A. Telomere-telomere recombination provides an express pathway for telomere acquisition. Nature 1990; 345: 456–8
   PubMed Web of Science ®Google Scholar
• Mason J M, Biessmann H. The unusual telomeres of Drosophila. Trends Genet 1995; 11: 58–62
   PubMed Web of Science ®Google Scholar